Could this mark a shift in how we think about cancer therapy? At least in the laboratory, evidence suggests it may be.

D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory ...

A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Communications, identifies a powerful strategy to overcome drug resistance in ...

Accurate risk stratification and treatment selection remain central challenges in cancer care. Rapid advances in medical imaging, digital pathology, and ...

The researchers examined the five leading causes of cancer death among the under-50 age group. They found that overall, from 1990 through 2023, more than 1.2 million people died of cancer in the ...

During February, colleagues from Bluedog Group agencies Essential Communications, doplr, HEX, Kounter and Underlined are proudly taking part in #KickCancerThon, collectively completing the marathon ...

In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or area is cancerous. However, in the U.S., between 75% and 80% of breast biopsies are benign.

Breast cancer survivors stitch surgical thread onto their own canvas portraits, exploring the body as a site of illness, ...

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy found that ...